Osiris Therapeutics competitors and similar companiesClear all

Osiris Therapeutics's competitors and similar companies include ACell, GeneDx, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical and Poseida Therapeutics.
Osiris Therapeutics
Osiris Therapeutics
Osiris Therapeutics is a company that researches, develops, manufactures, markets, and distributes regenerative medicine products.
ACell
ACell
ACell is a company focused on the development and commercialization of medical devices for wound management and surgical soft tissue repair.
GeneDx
GeneDx
GeneDx is a company operating in the genetics and genomics industry.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a company that manufactures biomedicine.
Poseida Therapeutics
Poseida Therapeutics
Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.
Founding Date
Founding Date
1992
Founding Date
2002
Founding Date
2000
Founding Date
1996
Founding Date
2015
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Public
Type
Private
Tags
Locations
Locations
Columbia, US HQ
Locations
Columbia, US HQ
Lafayette, US
Locations
Gaithersburg, US HQ
Locations
CN HQ
Locations
San Diego, US HQ
Employees
Employees
185
Employees
400
Employees
6122% increase
Employees
817
Employees
2801% increase
Alexa Website Rank
Alexa Website Rank
141951
Alexa Website Rank
323161
Alexa Website Rank
421995
Alexa Website Rank
110606
Alexa Website Rank
328746
Employee Rating
Employee Rating
2.7
Employee Rating
3.7
Employee Rating
3.3
Employee Rating
N/A
Employee Rating
4.6

Financial

Revenue (est.)
Revenue (est.)
$142.8m (FY, 2018)
Revenue (est.)
$100.8m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$38.1m (FY, 2018)
Cost of goods
$19.1m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$104.7m (FY, 2018)
Gross profit
$81.7m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
$36.9m (FY, 2018)
Net income
$1.4m (FY, 2019)
Net income
N/A
Net income
N/A
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 65m
Total funding raised
$ 8.7m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 336.5m
For sources of this data, please see the company profile

View company profiles

ACell
HQ
Columbia, US
Employees
400

ACell is a company focused on the development and commercialization of medical devices for wound management and surgical soft tissue repair.

View company
GeneDx
HQ
Gaithersburg, US

GeneDx is a company operating in the genetics and genomics industry.

View company
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
HQ
CN
Employees
817

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a company that manufactures biomedicine.

View company
Poseida Therapeutics
HQ
San Diego, US
Employees
280↑ 1% increase

Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.

View company